Royalty Pharma (RPRX) Offers Attractive Risk-Reward Profiles at Reasonable Multiples
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”. The letter can be downloaded here.




